Journal of Ophthalmology / 2018 / Article / Fig 1

Clinical Study

Topical Osmoprotectant for the Management of Postrefractive Surgery-Induced Dry Eye Symptoms: A Randomised Controlled Double-Blind Trial

Figure 1

Mean and SEM values of questionnaires scores compared between FT and Op groups before surgery (T0) and 1 month (T1) and 3 months (T3) after treatment. (a) Dryness scores. The score is significantly higher for Op group in T1 compared to T0 (Friedman test, ). (b) Pain scores. There was a significant increase between T0 and T3 for the FT group (Friedman test, ).
(a)
(b)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.